Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: Meta-analysis

To assess the benefits and risks of off-pump coronary artery bypass (OPCAB) versus coronary artery bypass grafting (CABG) through a meta-analysis of randomized controlled trials (RCTs), and to investigate the relationship between outcomes and patient risk profile. PubMed, Embase, the Cumulative Inde...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of thoracic and cardiovascular surgery Vol. 151; no. 1; pp. 60 - 77.e58
Main Authors Kowalewski, Mariusz, Pawliszak, Wojciech, Malvindi, Pietro Giorgio, Bokszanski, Marek Pawel, Perlinski, Damian, Raffa, Giuseppe Maria, Kowalkowska, Magdalena Ewa, Zaborowska, Katarzyna, Navarese, Eliano Pio, Kolodziejczak, Michalina, Kowalewski, Janusz, Tarelli, Giuseppe, Taggart, David Paul, Anisimowicz, Lech
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To assess the benefits and risks of off-pump coronary artery bypass (OPCAB) versus coronary artery bypass grafting (CABG) through a meta-analysis of randomized controlled trials (RCTs), and to investigate the relationship between outcomes and patient risk profile. PubMed, Embase, the Cumulative Index of Nursing and Allied Health Literature, Scopus, Web of Science, Cochrane Library, and major conference proceedings databases were searched for RCTs comparing OPCAB and CABG and reporting short-term (≤30 days) outcomes. Endpoints assessed were all-cause mortality, myocardial infarction (MI), and cerebral stroke. The meta-analysis included 100 studies, with a total of 19,192 subjects. There was no difference between the 2 techniques with respect to all-cause mortality and MI (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.71-1.09; P = .25; I2 = 0% and OR, 0.90; 95% CI, 0.77-1.05; P = .19; I2 = 0%, respectively). OPCAB was associated with a significant 28% reduction in the odds of cerebral stroke (OR, 0.72; 95% CI, 0.56-0.92; P = .009; I2 = 0%). A significant relationship between patient risk profile and benefits from OPCAB was found in terms of all-cause mortality (P < .01), MI (P < .01), and cerebral stroke (P < .01). OPCAB is associated with a significant reduction in the odds of cerebral stroke compared with conventional CABG. In addition, benefits of OPCAB in terms of death, MI, and cerebral stroke are significantly related to patient risk profile, suggesting that OPCAB should be strongly considered in high-risk patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0022-5223
1097-685X
1097-685X
DOI:10.1016/j.jtcvs.2015.08.042